Multidimensional Flow Cytometry for Detection of Rare Populations in Hematological Malignancies

Tzu Chi Medical Journal

Volumn 21, Issue 1, 2009, Pages 40-51

  Li, Chi Cheng ^a,b   Loken, Michael R ^c   Kao, Ruey Ho ^a,b   Wang, Tso Fu ^a,b   Tsai, Shii Shou ^a   Hsu, Shu Min ^a   Yao, Chao Yuan ^a,b   Li, Szu Chin ^a,b   Huang, Kuan Po ^a,b   Wu, Yi Feng ^a,b   Huang, Wei Han ^a,b   Chu, Sung Chao ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c HEMATOLOGICS INC   (United States)

Author keywords

Flow cytometry; Leukemia; Lymphoproliferative disorder; Minimal residual disease; Myelodysplastic syndrome

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; DAUNORUBICIN; IDARUBICIN; MITOXANTRONE; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; APLASTIC ANEMIA; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER STAGING; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LYMPHOPROLIFERATIVE DISEASE; MALE; MINIMAL RESIDUAL DISEASE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIDIMENSIONAL FLOW CYTOMETRY; MYELODYSPLASTIC SYNDROME; PROMYELOCYTIC LEUKEMIA; SENSITIVITY AND SPECIFICITY;

EID: 65549159909     PISSN: 10163190     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1016-3190(09)60007-0     Document Type: Article

References (23)

1. Terstappen L.W., Safford M., and Loken M.R. Flow cytometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia 4 (1990) 657-663
2. Loken M.R., Shah V.O., Dattilio K.L., and Civin C.I. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 70 (1987) 1316-1324
3. Loken M.R., and Wells D.A. Normal antigen expression in hema-topoiesis: basis for interpreting leukemia phenotypes. In: Stewart C.C., and Nicholson J. (Eds). Immunophenotyping (2000), Wiley-Liss, New York 133-160
4. Terstappen L.W., Safford M., Konemann S., et al. Flow cyto-metric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 5 (1991) 70-80
5. Terstappen L.W., and Loken M.R. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol 2 (1990) 229-240
6. Terstappen L.W., Safford M., Unterhalt M., et al. Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoi-etic progenitor cells. Leukemia 6 (1992) 993-1000
7. Hurwitz C.A., Loken M.R., Graham M.L., et al. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood 72 (1988) 299-307
8. Sievers E.L., Lange B.J., Alonzo T.A., et al. Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia. Blood 101 (2003) 3398-3406
9. Campana D., and Coustan-Smith E. Minimal residual disease studies by f low cytometr y in acute leukemia. Act a Haematol 112 (2004) 8-15
10. San Miguel J.F., Vidriales M.B., Lopez-Berges C., et al. Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification. Blood 98 (2001) 1746-1751
11. Venditti A., Buccisano F., Del Poeta G., et al. Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia. Blood 96 (2000) 3948-3952
12. Coustan-Smith E., Behm F.G., Sanchez J., et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukemia. Lancet 351 (1998) 550-554
13. Farahat N., Morilla A., Owusu-Ankomah K., et al. Detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by quantitative flow cytometry. Br J Haematol 101 (1998) 158-164
14. Coustan-Smith E., Sancho J., Behm F.G., et al. Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. Blood 100 (2002) 52-58
15. Stelzer G.T., Shults K.E., and Loken M.R. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann NY Acad Sci 677 (1993) 265-280
16. Sievers E.L., Lange B.J., Buckley J.D., et al. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. J Natl Cancer Inst 88 (1996) 1483-1488
17. Borowitz M.J., Guenther M.T., Shults K.E., and Stelzer G.T. Immu-nophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 100 (1993) 534-540
18. Reading C.L., Estey E.H., Huh Y.O., et al. Expression of unusual immunophenotype combinations in acute myeloid leukemia. Blood 81 (1993) 3083-3090
19. Greaves M.F., Chan L.C., Furley A.J., Watt S.M., and Molgaard H.V. Lineage promiscuity in hematopoietic differentiation and leukemia. Blood 67 (1986) 1-11
20. Wells D.A., Benesch M., Loken M.R., et al. Myeloid and mono-cytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 102 (2003) 394-403
21. Bowen K.L.D.B. Abnormal patterns of expression of CD16 (FcR-III) and CD11b (CR III) antigens by developing neu-trophils in the bone marrow of patients with myelodys-plastic syndrome. Lab Hematol 3 (1997) 292-298
22. Stetler-Stevenson M., Arthur D.C., Jabbour N., et al. Diagnostic utility of flow cytometric immunophenotyping in myelo-dysplastic syndrome. Blood 98 (2001) 979-987
23. Maynadie M., Picard F., Husson B., et al. Immunophenotypic clustering of myelodysplastic syndromes. Blood 100 (2002) 2349-2356